Publication | Open Access
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma
117
Citations
36
References
2019
Year
Lymphoid NeoplasiaMedicineImmunologyPhase Ii StudyImmune Checkpoint InhibitorPd-1 Inhibitor PembrolizumabAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1